Literature DB >> 2895813

Detection of alcohol-induced fatty liver by computerized tomography.

S L Allaway1, C D Ritchie, D Robinson, T Seear, R Reznek, I K Fry, G R Thompson.   

Abstract

Computerized tomographic (CT) scanning of the liver was undertaken in 17 occasional and 19 heavy drinkers undergoing health screening. The median attenuation value of the liver (CT number) in occasional drinkers with normal liver function tests was 54.4 compared with 25.9 in the heavy drinkers (P less than 0.001). Fourteen of the heavy drinkers had a CT number below the lowest value observed in occasional drinkers with normal liver function, indicating reduced liver density due to fatty change. Serum gamma-glutamyl transpeptidase was normal in 36% of these individuals. A rise in CT number was observed in 4 out of 5 heavy drinkers who underwent a second scan after decreasing their alcohol consumption. These findings suggest that CT scanning provides a noninvasive and convenient method of screening for a fatty liver, which occurred to a variable degree in over 70% of the men who admitted to regularly taking 8 or more alcoholic drinks per day.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895813      PMCID: PMC1291508          DOI: 10.1177/014107688808100310

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  11 in total

1.  Alcohol abstinence in alcoholic liver disease.

Authors:  G A Martini; R Teschke
Journal:  Acta Med Scand Suppl       Date:  1985

2.  Ultrasound scanning in the detection of hepatic fibrosis and steatosis.

Authors:  S H Saverymuttu; A E Joseph; J D Maxwell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

3.  Mean red cell volume as a marker of alcohol intake.

Authors:  T P Whitehead; C A Clarke; R I Bayliss; A G Whitfield
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

4.  Computed tomography in the diagnosis of fatty liver: total lipid content and computed tomography number.

Authors:  Y Yajima; T Narui; M Ishii; R Abe; M Ohtsuki; Y Goto; S Endo; K Yamada; M Ito
Journal:  Tohoku J Exp Med       Date:  1982-03       Impact factor: 1.848

5.  Biochemical and haematological markers of alcohol intake.

Authors:  T P Whitehead; C A Clarke; A G Whitfield
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

6.  Accuracy of computed tomography in diagnosis of fatty liver.

Authors:  G M Bydder; L Kreel; R W Chapman; D Harry; S Sherlock; L Bassan
Journal:  Br Med J       Date:  1980-10-18

7.  Mean cell volume and gamma-glutamyl-transpeptidase as markers of drinking in working men.

Authors:  J Chick; N Kreitman; M Plant
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

8.  A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease.

Authors:  D R Meek; P R Mills; H W Gray; J G Duncan; R I Russell; J H McKillop
Journal:  Br J Radiol       Date:  1984-01       Impact factor: 3.039

9.  Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis.

Authors:  T I Sørensen; M Orholm; K D Bentsen; G Høybye; K Eghøje; P Christoffersen
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

10.  Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic.

Authors:  L Van Waes; C S Lieber
Journal:  Br Med J       Date:  1977-12-10
View more
  3 in total

Review 1.  Hypertriglyceridaemia in diabetes.

Authors:  W Stuart A Smellie
Journal:  BMJ       Date:  2006-12-16

2.  Hepatic 'pseudotumours': an important diagnostic pitfall.

Authors:  M W Scriven; A Shandall; E J Fitzgerald; M C Puntis
Journal:  Ann R Coll Surg Engl       Date:  1993-01       Impact factor: 1.891

3.  Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.

Authors:  P D Peppercorn; R H Reznek; P Wilson; M L Slevin; R K Gupta
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.